Researchers from the Barcelona Laboratoy for Urban Environmental Justice and Sustainability (BCNUEJ) from the ICTA-UAB, in partnership with the Barcelona Institute for Global Health (ISGlobal), will coordinate and...
The Composting Research Group (GICOM) from the Chemical, Biological and Environmental Engineering Departament at UAB has developed an aroma producing process by yeast solid state fermentation (SSF) of organic waste from the sugar industry. This process is cleaner and more economic than the...
GaudiMM is a molecular design program developed in the department of Chemistry of the
...
EDO Group (Organizational Development Team) of the Applied Pedagogy Department Aplicada develops a national study about teachers’ perception about the impact of Information and Communication Technologies (ICT) in class. The analysis of the results show...
Luis Fernando Romo analyzes in his thesis the rumor phenomena and the impact it has in the lives of celebrities, who concoct their lives for public consumption. This study has been...
MEDIRAD is a European Commission-funded project that aims to enhance the radiation protection of patients and medical professionals against exposure to low doses of ionizing radiation for medical reasons. This multidisciplinary project will bring together...
Folicular Lymphoma (FL) is divided into 3 different grades. It seems that there is a relationship between the lower grades and some subtypes of diffuse large B-cell lymphoma (DLBCL), in the form of a biological continuum, with the grade 3 FL (FL3) as an intermediary. Although this...
The research group Bioinformatics of Genomic Diversity of the UAB, in collaboration with the Evolutionary Development Biology group of the University of Helsinki, have mapped by the first time phenotypic adaptation and...
The UAB Research Park has brought over 80 people in the presentation of the Bioindustrial Community for Bioeconomics (BBCAT), a proposal to promote innovative projects which can improve the
Researchers from the Biotechnology and Biomedicine Institut (IBB) at UAB have discovered a new therapeutical aproximation to Parkinson’s disease, focused on the alpha-synuclein, a protein involved in this and other neurodegenerative disorders, which’s...
